Delivery Order SPE2DB22D1106-SPE2DB25FFDN3
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Famotidine 20 mg Piggyback 50ml, a gastric acid reducer commonly used in military healthcare settings. This firm fixed-price delivery order, valued at $1,437.42, represents a non-competitive set-aside contract and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Famotidine 40 mg/5 ml suspension in 50 ml quantities, with a ceiling value of $1,392.09. The contract was awarded on August 14, 2025, on a firm fixed price basis with an ultimate completion date of August 15, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a $2,008.99 delivery order to AmerisourceBergen Drug Corp for the supply of Famotidine 40 mg/5 ml suspension in 50 ml quantities. This firm fixed-price, competitively awarded contract was executed on June 3, 2025, with an ultimate completion date of June 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a routine pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,796.76 firm fixed-price delivery order is for the supply of 4,564,943,591 units of Famotidine 20 mg Piggyback 50 ml, a medication used to treat various gastrointestinal conditions. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $25,807.41 firm fixed-price contract is for the delivery of 4,565,286 units of Famotidine 40 mg tablets. The contract has a period of performance through July 30, 2024 and does not utilize a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $323.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561357320 famotidine 20 mg piggyback 50ml. The single day order from June 27-28, 2023 is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support DLA's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen will deliver the requested medications through its corporate distribution division without involving major...
- This is a $47,427.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 bottles of 40mg Famotidine tablets. The contract has a completion date of June 14, 2023 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a delivery order valued at $1,194.31 for the supply of FAMOTIDINE 20 MG PIGGYBACK 50ML, a pharmaceutical product. The contract is a firm fixed price award with a completion date of February 7, 2024. It is not designated as a set-aside contract. Amerisourcebergen...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $1,302.64, is for the supply of 4564170533 - Famotidine 40 mg/5 ml suspension, 50 ml. The order has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $20,653.08, is for the delivery of 4564222237 Famotidine 40 mg tablets to support military treatment programs and medical facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDN3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Famotidine 20 mg Piggyback 50ml with a ceiling value of $2,156.13. This is a firm fixed-price delivery order issued under a child contract arrangement, with performance to be completed by August 18, 2025, at the vendor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the parent vehicle for this and similar delivery orders. AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical commodities to support military and federal healthcare systems. This delivery order for Famotidine, a common gastrointestinal medication, represents routine pharmaceutical procurement through the company's extensive federal contract portfolio. The vendor's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its substantial prime vendor status with DLA, positions it as a critical provider within the Defense Health Agency's pharmaceutical supply chain serving military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/15/25 |